SFM
NMTR

Sphera Funds Management’s 9 Meters Biopharma NMTR Stock Holding History

Sphera Funds Management’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-49,025
Closed -$7.84M – 133
2018
Q2 		$7.84M Hold
49,025
– – 1.08% 21
2018
Q1 		$12.3M Buy
+49,025
New +$9.54M 1.86% 13

Other funds holding NMTR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Sphera Funds Management's NMTR Position: Q3 2018 in Review

Sphera Funds Management sold out of 9 Meters Biopharma (NMTR) in Q3 2018, closing a stake of 49,025 shares — an estimated $7.84M sold.

Sphera Funds Management first reported a position in NMTR in Q1 2018 and held it in 2 quarters. The position peaked at $12.3M in Q1 2018. 45 funds tracked by Wall St. Rank hold NMTR as of Q3 2018.

  • Sphera Funds Management reported no remaining 9 Meters Biopharma position as of Q3 2018 after selling out during the quarter.
  • Sphera Funds Management sold 49,025 9 Meters Biopharma shares in Q3 2018, an estimated $7.84M.
  • Sphera Funds Management first reported a position in 9 Meters Biopharma in Q1 2018 and held it in 2 quarters.
  • Sphera Funds Management's 9 Meters Biopharma position peaked at $12.3M in Q1 2018.
  • 45 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2018.

Based on Sphera Funds Management's 13F filing for Q3 2018, filed 14 Nov 2018.